The CMIL team presented eight posters covering histopathological image analysis, drug treatment response in lupus nephritis, detection and scoring of microvascular inflammation in kidney allografts, and single-cell molecular characterization of neovascularization in chronic kidney disease.
Dr. Sarder served as a session moderator, providing updates on cutting-edge techniques and accomplishments from scientists at the forefront of basic science in diabetic kidney disease. He presented a talk on the role of generative AI in pathology and participated as a panelist, where he discussed the potential of AI to identify new disease mechanisms and therapeutic targets.